î
îž
î
Medtronic PLC
MDT98.660USD
-1.210-1.21%
āđāļ§āļĨāļēāļāļģāļāļēāļĢāļāļĨāļēāļÂ ïžETïžāļĢāļēāļāļēāļĨāđāļēāļāđāļē 15 āļāļēāļāļĩ
126.48BāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
26.55P/E TTM
î
āļĢāļēāļĒāļĨāļ°āđāļāļĩāļĒāļāđāļāļīāđāļĄāđāļāļīāļĄāļāļāļ Medtronic PLC āļāļĢāļīāļĐāļąāļ
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Companyâs products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
āļāđāļāļĄāļđāļĨ Medtronic PLC
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMDT
āļāļ·āđāļāļāļĢāļīāļĐāļąāļMedtronic PLC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 21, 1977
āļāļĩāļāļĩāđāļMartha (Geoffrey S)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ95000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļNov 21
āļāļĩāđāļāļĒāļđāđBuilding Two Parkmore Business Park West
āđāļĄāļ·āļāļDUBLIN
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻIreland
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđH91 4K49
āđāļāļĢāļĻāļąāļāļāđ1135314381700
āđāļ§āđāļāđāļāļāđhttps://www.medtronic.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMDT
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 21, 1977
āļāļĩāļāļĩāđāļMartha (Geoffrey S)
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ Medtronic PLC
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+0.89%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+0.41%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+0.89%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-81.26%
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
āļŠāļąāļāļŠāđāļ§āļāļāļāļāļĢāļēāļĒāđāļāđ
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 6 āļ.āļ.
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 6 āļ.āļ.
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
āļāļ·āđāļ āđ
2.41B
28.11%
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Rest of World
4.32B
50.37%
United States
4.22B
49.24%
Ireland
33.00M
0.38%
āļāļēāļĄāļāļļāļĢāļāļīāļ
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļ
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
āļāļ·āđāļ āđ
2.41B
28.11%
āļŠāļāļīāļāļīāļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 17 āļ.āļĒ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 17 āļ.āļĒ.
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
āļāļ·āđāļ āđ
74.57%
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
āļāļ·āđāļ āđ
74.57%
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
Investment Advisor
46.90%
Investment Advisor/Hedge Fund
29.42%
Research Firm
4.18%
Pension Fund
2.40%
Bank and Trust
2.17%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Insurance Company
0.38%
Individual Investor
0.28%
āļāļ·āđāļ āđ
11.49%
āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļļāļāļāļĩāđ 1 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļļāļāļāļĩāđ 1 āļ.āļ.
āļāđāļ§āļāđāļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļāļēāļ
āļāļģāļāļ§āļāļŠāļāļēāļāļąāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļīāļāļāļĢāļĢāļĄāļāļđāđāļāļ·āļāļŦāļļāđāļ
îāļāļ·āđāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
āđāļāļĨāļĩāđāļĒāļ%
āļ§āļąāļāļāļĩāđ
The Vanguard Group, Inc.
126.32M
9.85%
+1.88M
+1.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
67.84M
5.29%
-1.09M
-1.58%
Jun 30, 2025
State Street Investment Management (US)
59.83M
4.66%
-210.22K
-0.35%
Jun 30, 2025
JP Morgan Asset Management
26.31M
2.05%
-1.69M
-6.03%
Jun 30, 2025
Capital Research Global Investors
36.36M
2.83%
-5.21M
-12.53%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.23M
2.2%
+310.68K
+1.11%
Jun 30, 2025
MFS Investment Management
19.36M
1.51%
-1.24M
-6.04%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
13.77M
1.07%
-170.61K
-1.22%
Jun 30, 2025
BlackRock Financial Management, Inc.
15.63M
1.22%
+1.48M
+10.48%
Jun 30, 2025
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
ETF āļāļĩāđāđāļāļĩāđāļĒāļ§āļāđāļāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāđāļŠāļēāļĢāđāļāļĩāđ 6 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāđāļŠāļēāļĢāđāļāļĩāđ 6 āļ.āļ.
āļāļ·āđāļ
āļŠāļąāļāļŠāđāļ§āļ
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Absolute Select Value ETF
āļŠāļąāļāļŠāđāļ§āļ4.89%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ4.4%
iShares Health Innovation Active ETF
āļŠāļąāļāļŠāđāļ§āļ4.26%
Cullen Enhanced Equity Income ETF
āļŠāļąāļāļŠāđāļ§āļ4.24%
USCF Dividend Income Fund
āļŠāļąāļāļŠāđāļ§āļ3.59%
JPMorgan Healthcare Leaders ETF
āļŠāļąāļāļŠāđāļ§āļ3.22%
Madison Dividend Value ETF
āļŠāļąāļāļŠāđāļ§āļ3.08%
Tema Heart & Health ETF
āļŠāļąāļāļŠāđāļ§āļ2.98%
Global X Aging Population ETF
āļŠāļąāļāļŠāđāļ§āļ2.98%
WisdomTree US AI Enhanced Value Fund
āļŠāļąāļāļŠāđāļ§āļ2.86%
āđāļāļīāļāļāļąāļāļāļĨ
îāļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
17.37B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
āļ§āļąāļāļāļĩāđ
āđāļāļīāļāļāļąāļāļāļĨ
āļ§āļąāļāļāļĩāđāļāļąāļāļāļķāļ
āļ§āļąāļāļāļĩāđāļāļģāļĢāļ°āđāļāļīāļ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļēāļĢāđāļāđāļāļŦāļļāđāļ
îāļ§āļąāļāļāļĩāđ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
āļ§āļąāļāļāļĩāđ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
āļāļģāļāļēāļĄāļāļĩāđāļāļāļāđāļāļĒ
āđāļāļĢāļāļ·āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Medtronic PLC?
îāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Medtronic PLC āđāļāđāđāļāđ:
The Vanguard Group, Inc. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 126.32M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 9.85% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
BlackRock Institutional Trust Company, N.A. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 67.84M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 5.29% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
State Street Investment Management (US) āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 59.83M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 4.66% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
JP Morgan Asset Management āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 26.31M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.05% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Capital Research Global Investors āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 36.36M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.83% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
The Vanguard Group, Inc. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 126.32M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 9.85% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
BlackRock Institutional Trust Company, N.A. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 67.84M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 5.29% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
State Street Investment Management (US) āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 59.83M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 4.66% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
JP Morgan Asset Management āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 26.31M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.05% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Capital Research Global Investors āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 36.36M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.83% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŠāļēāļĄāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Medtronic PLC āļāļ·āļāļāļ°āđāļĢ?
îāļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŠāļēāļĄāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Medtronic PLC āđāļāđāđāļāđ
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
āļĄāļĩāļāļĩāđāļŠāļāļēāļāļąāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ Medtronic PLC (MDT)?
îāļ āļ§āļąāļāļāļĩāđ 2025Q3 āļĄāļĩāļŠāļāļēāļāļąāļāļāļģāļāļ§āļ 3723 āđāļŦāđāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ Medtronic PLC āđāļāļĒāļĄāļĩāļĄāļđāļĨāļāđāļēāļĢāļ§āļĄāļāļĢāļ°āļĄāļēāļ 1.13B āļāļīāļāđāļāđāļ 88.20% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ āđāļĄāļ·āđāļāđāļāļĩāļĒāļāļāļąāļāļ§āļąāļāļāļĩāđ 2025Q2 āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļāđāļāđāđāļāļīāđāļĄāļāļķāđāļ 1.08%
āđāļŦāļĨāđāļāļĢāļēāļĒāđāļāđāļŦāļĨāļąāļāļāļāļ Medtronic PLC āļāļ·āļāļāļ°āđāļĢ?
îāđāļĄāļ·āđāļāļ§āļąāļāļāļĩāđ FY2026Q1 āļāļļāļĢāļāļīāļāļāđāļēāļ Cardiac Rhythm & Heart Failure āļŠāļĢāđāļēāļāļĢāļēāļĒāđāļāđāļŠāļđāļāļŠāļļāļāđāļŦāđāļāļąāļ Medtronic PLC āļāļīāļāđāļāđāļāļĄāļđāļĨāļāđāļē 1.71B āđāļĨāļ°āļāļīāļāđāļāđāļ 19.96% āļāļāļāļĢāļēāļĒāđāļāđāļĢāļ§āļĄ
